McKesson Corporation (MCK) P/E Ratio History
UndervaluedTrading at 20.4x vs 5Y avg 24.0x · 25th percentile · Below historical baseline · Data 1996–2026
Loading P/E history...
P/E Ratio Analysis
As of July 7, 2026, McKesson Corporation (MCK) trades at a price-to-earnings ratio of 20.4x, with a stock price of $784.23 and trailing twelve-month earnings per share of $38.81.
The current P/E is 15% below its 5-year average of 24.0x. Over the past five years, MCK's P/E has ranged from a low of 11.3x to a high of 42.5x, placing the current valuation at the 25th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.5x, MCK is roughly in line with its sector peers. The sector includes 231 companies with P/E ratios ranging from 0.0x to 199.4x.
Relative to the broader market, MCK trades at a notable discount to the S&P 500 median P/E of 25.6x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our MCK DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
MCK Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
MCK P/E vs Peers
Drug Wholesalers and Distributors peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $56B | 36.8 | - | +87% | |
| $10B | 26.5 | 8.40 | +7% | |
| $130B | 73.4 | - | -62% | |
| $74B | 12.7Lowest | - | +83% | |
| $624B | 23.5 | 1.58 | +91%Best | |
| $135B | 17.4 | - | -4% | |
| $313B | 17.4 | 0.82Best | +8% | |
| $450B | 107.5 | - | -1% | |
| $413B | 24.7 | 4.85 | +34% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
MCK Historical P/E Data (1996–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q4 | - | $865.36 | $38.47 | 22.5x | -66% |
| FY2026 Q3 | Dec 31 2025 | $820.29 | $34.77 | 23.6x | -64% |
| FY2026 Q2 | - | $772.54 | $32.12 | 24.1x | -64% |
| FY2026 Q1 | Jun 30 2025 | $732.78 | $25.06 | 29.2x | -56% |
| FY2025 Q4 | Mar 31 2025 | $672.99 | $25.81 | 26.1x | -61% |
| FY2025 Q3 | - | $569.91 | $21.81 | 26.1x | -61% |
| FY2025 Q2 | Sep 30 2024 | $494.42 | $19.29 | 25.6x | -61% |
| FY2025 Q1 | Jun 30 2024 | $584.04 | $22.36 | 26.1x | -61% |
| FY2024 Q4 | Mar 31 2024 | $536.85 | $22.37 | 24.0x | -64% |
| FY2024 Q3 | Dec 31 2023 | $462.98 | $22.06 | 21.0x | -68% |
| FY2024 Q2 | Sep 30 2023 | $434.85 | $25.29 | 17.2x | -74% |
| FY2024 Q1 | Jun 30 2023 | $427.31 | $26.79 | 16.0x | -76% |
| FY2023 Q4 | Mar 31 2023 | $356.05 | $25.04 | 14.2x | -79% |
| FY2023 Q3 | Dec 31 2022 | $375.12 | $21.81 | 17.2x | -74% |
| FY2023 Q2 | Sep 30 2022 | $339.87 | $14.11 | 24.1x | -64% |
| FY2023 Q1 | - | $326.21 | $9.39 | 34.7x | -48% |
| FY2022 Q4 | - | $306.13 | $7.20 | 42.5x | -36% |
| FY2022 Q3 | Dec 31 2021 | $248.57 | $8.88 | 28.0x | -58% |
| FY2021 Q2 | Sep 30 2020 | $148.93 | $13.14 | 11.3x | -83% |
| FY2021 Q1 | - | $153.42 | $5.61 | 27.3x | -59% |
| FY2020 Q4 | - | $135.26 | $5.13 | 26.4x | -60% |
| FY2020 Q1 | Jun 30 2019 | $134.39 | $2.98 | 45.1x | -32% |
| FY2019 Q4 | Mar 31 2019 | $117.06 | $0.06 | 1951.0x | +2840% |
| FY2019 Q2 | Sep 30 2018 | $132.65 | $0.60 | 221.1x | +233% |
| FY2018 Q4 | Mar 31 2018 | $140.87 | $0.23 | 612.5x | +823% |
| FY2018 Q3 | Dec 31 2017 | $155.95 | $22.55 | 6.9x | -90% |
| FY2018 Q2 | Sep 30 2017 | $153.61 | $21.07 | 7.3x | -89% |
| FY2018 Q1 | Jun 30 2017 | $164.54 | $22.40 | 7.3x | -89% |
| FY2017 Q4 | Mar 31 2017 | $148.26 | $23.33 | 6.4x | -90% |
| FY2017 Q3 | Dec 31 2016 | $140.45 | $8.45 | 16.6x | -75% |
| FY2017 Q2 | Sep 30 2016 | $166.75 | $8.33 | 20.0x | -70% |
| FY2017 Q1 | - | $186.65 | $9.62 | 19.4x | -71% |
| FY2016 Q4 | - | $157.25 | $9.69 | 16.2x | -76% |
| FY2016 Q3 | - | $197.23 | $8.37 | 23.6x | -64% |
| FY2016 Q2 | Sep 30 2015 | $185.03 | $7.64 | 24.2x | -64% |
| FY2016 Q1 | - | $224.81 | $7.00 | 32.1x | -52% |
| FY2015 Q4 | - | $226.20 | $6.27 | 36.1x | -46% |
| FY2015 Q3 | Dec 31 2014 | $207.58 | $7.29 | 28.5x | -57% |
| FY2015 Q2 | - | $194.67 | $5.57 | 34.9x | -47% |
| FY2015 Q1 | Jun 30 2014 | $186.21 | $5.32 | 35.0x | -47% |
| FY2014 Q4 | Mar 31 2014 | $176.57 | $5.43 | 32.5x | -51% |
| FY2014 Q3 | - | $161.40 | $4.99 | 32.3x | -51% |
| FY2014 Q2 | Sep 30 2013 | $128.30 | $5.95 | 21.6x | -68% |
| FY2014 Q1 | Jun 30 2013 | $114.50 | $5.88 | 19.5x | -71% |
| FY2013 Q4 | Mar 31 2013 | $107.96 | $5.63 | 19.2x | -71% |
| FY2013 Q3 | Dec 31 2012 | $96.96 | $6.70 | 14.5x | -78% |
| FY2013 Q2 | Sep 30 2012 | $86.03 | $6.66 | 12.9x | -81% |
| FY2013 Q1 | Jun 30 2012 | $93.75 | $6.17 | 15.2x | -77% |
| FY2012 Q4 | Mar 31 2012 | $87.77 | $5.72 | 15.3x | -77% |
| FY2012 Q3 | Dec 31 2011 | $77.91 | $5.20 | 15.0x | -77% |
| FY2012 Q2 | Sep 30 2011 | $72.70 | $4.60 | 15.8x | -76% |
| FY2012 Q1 | - | $83.65 | $4.67 | 17.9x | -73% |
| FY2011 Q4 | - | $79.05 | $4.64 | 17.0x | -74% |
| FY2011 Q3 | Dec 31 2010 | $70.38 | $4.26 | 16.5x | -75% |
| FY2011 Q2 | - | $61.78 | $4.85 | 12.7x | -81% |
| FY2011 Q1 | Jun 30 2010 | $67.16 | $4.71 | 14.3x | -79% |
| FY2010 Q4 | Mar 31 2010 | $65.72 | $4.67 | 14.1x | -79% |
| FY2010 Q3 | - | $62.50 | $4.40 | 14.2x | -79% |
| FY2010 Q2 | Sep 30 2009 | $59.55 | $3.14 | 19.0x | -71% |
| FY2010 Q1 | - | $44.00 | $3.20 | 13.8x | -79% |
| FY2009 Q4 | - | $35.04 | $2.97 | 11.8x | -82% |
| FY2009 Q3 | Dec 31 2008 | $38.73 | $3.04 | 12.8x | -81% |
| FY2009 Q2 | - | $53.81 | $3.79 | 14.2x | -79% |
| FY2009 Q1 | Jun 30 2008 | $55.91 | $3.45 | 16.2x | -76% |
| FY2008 Q4 | Mar 31 2008 | $52.37 | $3.39 | 15.4x | -77% |
| FY2008 Q3 | Dec 31 2007 | $65.51 | $3.15 | 20.8x | -69% |
| FY2008 Q2 | Sep 30 2007 | $58.79 | $3.27 | 18.0x | -73% |
| FY2008 Q1 | Jun 30 2007 | $59.64 | $3.19 | 18.7x | -72% |
| FY2007 Q4 | Mar 31 2007 | $58.54 | $3.02 | 19.4x | -71% |
| FY2007 Q3 | Dec 31 2006 | $50.70 | $2.88 | 17.6x | -73% |
| FY2007 Q2 | Sep 30 2006 | $52.72 | $2.69 | 19.6x | -70% |
| FY2007 Q1 | Jun 30 2006 | $47.28 | $2.47 | 19.1x | -71% |
| FY2006 Q4 | Mar 31 2006 | $52.13 | $2.42 | 21.5x | -68% |
| FY2006 Q3 | Dec 31 2005 | $51.59 | $2.55 | 20.2x | -70% |
| FY2005 Q2 | - | $25.65 | $1.99 | 12.9x | -81% |
| FY2005 Q1 | Jun 30 2004 | $34.33 | $2.23 | 15.4x | -77% |
| FY2004 Q4 | Mar 31 2004 | $30.09 | $2.21 | 13.6x | -79% |
| FY2004 Q3 | Dec 31 2003 | $32.16 | $2.09 | 15.4x | -77% |
| FY2004 Q2 | - | $33.29 | $2.14 | 15.6x | -77% |
| FY2004 Q1 | Jun 30 2003 | $35.74 | $2.03 | 17.6x | -73% |
| FY2003 Q4 | Mar 31 2003 | $24.93 | $1.89 | 13.2x | -80% |
| FY2003 Q3 | - | $27.03 | $1.70 | 15.9x | -76% |
| FY2003 Q2 | Sep 30 2002 | $28.33 | $1.61 | 17.6x | -73% |
| FY2003 Q1 | Jun 30 2002 | $32.70 | $1.46 | 22.4x | -66% |
| FY2002 Q4 | Mar 31 2002 | $37.43 | $1.43 | 26.2x | -61% |
| FY2002 Q3 | Dec 31 2001 | $37.40 | $0.38 | 98.4x | +48% |
| FY2002 Q2 | Sep 30 2001 | $37.79 | $0.02 | 1889.5x | +2747% |
| FY2001 Q3 | Dec 31 2000 | $35.89 | $1.96 | 18.3x | -72% |
| FY2001 Q2 | Sep 30 2000 | $30.56 | $2.53 | 12.1x | -82% |
| FY2001 Q1 | Jun 30 2000 | $20.94 | $2.52 | 8.3x | -87% |
| FY2000 Q4 | Mar 31 2000 | $21.00 | $2.55 | 8.2x | -88% |
| FY2000 Q3 | Dec 31 1999 | $22.50 | $1.01 | 22.3x | -66% |
| FY2000 Q2 | - | $29.00 | $0.61 | 47.7x | -28% |
| FY2000 Q1 | Jun 30 1999 | $32.19 | $0.50 | 64.6x | -3% |
| FY1999 Q4 | Mar 31 1999 | $66.00 | $0.68 | 97.3x | +47% |
| FY1999 Q3 | - | $79.06 | $1.09 | 72.5x | +9% |
| FY1999 Q2 | Sep 30 1998 | $91.63 | $1.34 | 68.4x | +3% |
| FY1999 Q1 | - | $81.50 | $1.65 | 49.4x | -26% |
| FY1998 Q4 | - | $57.75 | $1.61 | 35.9x | -46% |
| FY1998 Q3 | Dec 31 1997 | $54.19 | $1.64 | 33.0x | -50% |
| FY1998 Q2 | - | $50.97 | $1.65 | 30.9x | -53% |
| FY1998 Q1 | Jun 30 1997 | $38.75 | $1.56 | 24.8x | -63% |
| FY1997 Q4 | Mar 31 1997 | $32.00 | $0.96 | 33.3x | -50% |
| FY1997 Q3 | - | $27.94 | $0.97 | 28.8x | -57% |
| FY1997 Q2 | Sep 30 1996 | $23.69 | $0.88 | 26.9x | -59% |
| FY1997 Q1 | Jun 30 1996 | $23.81 | $0.90 | 26.5x | -60% |
| FY1996 Q4 | Mar 31 1996 | $25.63 | $1.46 | 17.6x | -74% |
| FY1996 Q3 | Dec 31 1995 | $25.31 | $1.46 | 17.3x | -74% |
Average P/E for displayed period: 66.4x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
30+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
MCK — Frequently Asked Questions
Quick answers to the most common questions about buying MCK stock.
What is MCK's P/E ratio?
McKesson Corporation (MCK) trailing twelve-month P/E ratio is 20.4x, based on TTM diluted EPS of $38.81. The 5-year average P/E is 24.0x and the historical range spans 11.3x to 42.5x.
Is MCK stock overvalued or undervalued?
MCK trades at 20.4x P/E, near its 5-year average of 24.0x. The 25th percentile ranking within the 11.3x–42.5x historical range places valuation within normal bounds.
Is MCK stock expensive?
MCK is fairly valued relative to its own history. The current P/E of 20.4x is near the 5-year average of 24.0x (25th percentile of historical range).
What is MCK's historical P/E range?
Over the past 5 years, MCK's P/E ratio has ranged from 11.3x to 42.5x, with a median of 24.1x and an average of 24.0x. The current P/E of 20.4x places the stock at the 25th percentile of this range. Full historical data spans 1996–2026.
How does MCK's P/E compare to the S&P 500?
MCK trades at 20.4x P/E versus the S&P 500 median of 25.6x. The 20% discount to the market suggests lower growth expectations or perceived higher risk.
How does MCK's valuation compare to Healthcare peers?
McKesson Corporation P/E of 20.4x compares to the Healthcare sector median of 23.5x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is MCK's PEG ratio?
MCK PEG ratio is N/A, based on a P/E of 20.4x and EPS growth of 49.2%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is MCK's earnings yield?
MCK earnings yield is 4.89%, the inverse of its 20.4x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.